摘要
目的研究大剂量环磷酰胺(HD—CTX)联合粒细胞集落刺激因子(G—CSF)在多发性骨髓瘤(MM)造血干细胞动员中的临床疗效和安全性。方法选择2006年6月至2010年9月中山大学附属第一医院血液科36例MM患者,全部患者接受HD—CTX联合G—CSF动员,CTX3~5g/m2,第1天,G—CSF300μg/d第2天起直到干细胞采集结束。结果35例(97.2%)动员成功,其中31例第一次动员即成功,4例第二次动员成功。干细胞采集的中位时间为第11(9~13)天,22例(62.9%)患者采集1次,13例(37.1%)患者采集2次。采集的单个核细胞(MNC)数为(4.49±1.71)×10^8/kg,CD34+细胞数为(3.21±1.87)×10。/kg。7例疗效在动员后得到进一步提高。动员的非血液系统副反应包括恶心、呕口王11例(26.8%)、腹痛腹泻5例(12.2%)、发热7例(17.1%)、骨痛4例(9.8%)等。只有1例因感染影响干细胞采集。结论HD—CTX联合G—CSF是MM造血干细胞动员的安全有效的方法。
Objective To explore the efficacy and safety of high-dose cyclophosphamide (CTX)with granuloeyte colony-stimulating factor for mobilization of autologous peripheral blood stem cells in patients with muhiple myeloma. Methods 36 cases with muhiple myeloma receiced HD-CTX 3 × 5 g/m2 on day 1 and G-CSF 300 txg/d was used on day 2 and given daily subcutaneously until stem cells collection was completed. Results Mobilization was successful in 35/36 (97.2%)patients. Collection was started on days 11 (9 - 13 ). Enough stem cells was acqired in 22 cases(62. 9% ) by one leukopherese. However, 13 eases(37. 1% ) need twice. The mean number of MNC was(4. 49 ±2 1.71 )× 10^8/kg and CD34 + was(3.21 ± 1.87 ) × 10^6/kg. The clinical effects of 7/ 35 patients were improved after mobilization. Non-hematological adverse events included nausea and vomiting 11 (26. 8% ) ,diarrhea 5(12. 2% ) ,fever 7(17. 1% ) ,bone pain 4(9. 8% ). All of these adverse reactions could be controlled with routine supportive treatmemt. Only one failue to mobilization due to infection. Conclusion HD-CTX with granulocyte colony-stimulating factor is an effective and safe mobilizing regimen for autologous peripheral blood stem progenitor cells in patients with multiple myeloma.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2011年第7期530-532,共3页
Chinese Journal of Practical Internal Medicine
基金
广东省自然科学基金(8151008901000064)